Source of Stem Cell Rescue: Bone Marrow versus Peripheral Blood Progenitors

Stephanie F. Williams*, Todd Zimmerman, Gary Grad, Rosemarie Mick

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Sustained hematopoiesis can be restored after dose-intensive chemotherapy utilizing stem cells from either bone marrow and/or peripheral blood. Numerous reports have demonstrated the effectiveness of peripheral blood progenitors (PBPC) in restoring hematopoiesis. Here, we review data comparing the recovery among patients rescued with various stem cell sources after dose-intensive therapy. PBPC used alone or to augment autologous bone marrow to achieve timely hematopoietic recovery after dose-intensive therapy can result in shortened hospital stays, decreased transfusion requirements, and antibiotic usage. This will lead to increased application of dose-intensive therapy either singly or in multiple courses to treat various malignancies.

Original languageEnglish (US)
Pages (from-to)521-523
Number of pages3
JournalJournal of Hematotherapy and Stem Cell Research
Issue number4
StatePublished - 1993

ASJC Scopus subject areas

  • Immunology
  • Hematology


Dive into the research topics of 'Source of Stem Cell Rescue: Bone Marrow versus Peripheral Blood Progenitors'. Together they form a unique fingerprint.

Cite this